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See related research by Brkic et al., http://arthritis-research.com/content/16/2/R62 and
related letter by Dolff et al., http://arthritis-research.com/content/16/3/409We would like to reply to the letter by Dolff and colleagues
[1] regarding our article in a recent issue of Arthritis
Research & Therapy [2]. We thank the authors for their
interest in our work and the critical reading of our article.
The aim of our study was to investigate a possible associ-
ation between the IFN type I signature and memory T
helper 17 (Th17) cells and their cytokines in systemic lupus
erythematosus (SLE). Since CCR6 can be expressed by
regulatory T (Treg) cells, we have excluded CD25high cells
to discriminate between CD4+CD45RO+CCR6+CD25−
(primary Th17 cells) and Treg cells. Concerning the obser-
vation on co-expression of IL-17A with IFN-γ, we would
like to remark that IFN-γ is an IFN type II, and not an IFN
type I, cytokine and does not bind to the IFN type I recep-
tor. Detection of IFN type I activity is hampered by the
difficulty to assess the different subtypes of this cytokine.
Therefore, analysis of IFN type I-induced gene expression
in RNA from peripheral blood cells, the so-called IFN type
I signature, is used as a measure for IFN type I activity.
Although we fully agree with the authors that the relation-
ship between Th cells and IFN type I deserves further
study, their remark on the ‘genetic’ signature is confusing
and probably refers to the IFN type I-induced gene
expression signature, which is detected at the RNA level.
The relationship between CD25+ Tregs and IFN type I is
certainly of interest for further study as these Tregs are
carrying the IFN type I receptor and thus respond to in-
creased systemic IFN type I activity in SLE. Also, follow-up
studies with a focus on adaptive and innate cells producing* Correspondence: e.lubberts@erasmusmc.nl
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plasticity, will be of interest [3, 4]. In our article, we
presented data supporting a potential co-activity between
IFN type I and CD4+memory CCR6+ Th17 cytokines.
Further studies are needed to confirm this co-activity with
a focus on revealing the mechanism of this dangerous link
in SLE.
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